|
Delayed
Toronto S.E.
21:22:03 20/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 9.680 CAD | +5.45% |
|
-2.22% | +22.22% |
| 10-05 | Satellos Bioscience Granted Composition of Matter Patent for Forazapadin by USPTO | MT |
| 10-05 | Satellos Bioscience Receives US Patent for Forazapadin | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +5.45% | -2.22% | -24.79% | -17.41% | +22.22% | +2.11% | +101.67% | -46.22% | - | 138M | |
| +0.79% | -6.46% | -7.71% | +25.25% | +62.91% | +52.86% | +71.34% | +1.83% | - | 65.83B | |
| +1.92% | +10.35% | +13.88% | +10.62% | +16.21% | +13.02% | +87.74% | -14.94% | +237.66% | 51.87B | |
| +6.91% | +8.57% | -10.12% | +3.53% | +8.84% | +6.88% | +72.12% | +206.56% | +5,247.50% | 51.2B | |
| +0.78% | +3.00% | -0.51% | +31.69% | +19.12% | +26.63% | +45.64% | +6.75% | +260.80% | 43.76B | |
| +3.36% | +9.55% | +4.58% | +23.13% | +25.87% | +20.03% | +131.47% | +2.63% | +1,059.52% | 42.09B | |
| +7.48% | +4.08% | +1.74% | +8.72% | +146.23% | +263.12% | +601.18% | +628.26% | - | 39.04B | |
| -0.40% | +9.42% | +10.03% | +12.29% | +14.51% | +18.44% | +59.06% | +10.14% | +162.29% | 34B | |
| +3.84% | -4.94% | -0.60% | +35.34% | +59.19% | +42.35% | +8.92% | -57.55% | - | 25.2B | |
| +2.36% | +5.34% | +15.13% | +40.88% | +28.37% | +30.98% | +26.07% | -11.13% | +125.09% | 22.8B | |
| +1.87% | +1.74% | -7.59% | -1.74% | -4.87% | -16.11% | -0.38% | -66.39% | - | 22.41B | |
| +0.66% | -1.01% | -20.82% | -10.47% | -44.95% | -42.94% | +282.02% | +258.70% | +580.95% | 20.81B | |
| +0.69% | +2.35% | +0.00% | +18.24% | +11.14% | +14.66% | +172.29% | +231.94% | +1,919.48% | 17.3B | |
| -1.70% | -2.53% | -2.12% | -3.35% | +172.60% | +148.30% | +359.39% | +1,412.56% | +703.28% | 14.99B | |
| +2.12% | +7.86% | +12.18% | +15.60% | +46.45% | +85.84% | +204.07% | +196.63% | +446.76% | 15.53B | |
| +0.08% | +0.69% | +1.20% | +11.11% | +26.60% | +23.63% | +71.78% | -29.45% | +86.81% | 15.37B | |
| +1.88% | +5.10% | -1.26% | -6.82% | - | - | - | - | - | 15.1B | |
| +5.13% | +5.56% | +13.13% | +43.67% | +58.23% | +71.41% | +70.24% | -25.10% | +280.29% | 14.32B | |
| +3.54% | +4.05% | +1.39% | -3.78% | +19.33% | +2.09% | +498.47% | - | - | 13.77B | |
| +4.16% | +6.98% | +3.69% | +5.79% | -3.52% | -6.71% | -22.46% | -36.38% | +107.49% | 12.97B | |
| Average | +2.55% | -0.59% | +0.07% | +12.11% | +36.03% | +39.82% | +149.51% | +148.27% | +862.92% | 26.93B | |
| Weighted average by Cap. | +2.60% | +0.23% | +0.76% | +15.41% | +37.49% | +44.08% | +139.20% | +126.24% | +1,162.10% |
- Stock Market
- Stocks
- MSCL Stock
- Sector Satellos Bioscience Inc.
Select your edition
All financial news and data tailored to specific country editions
